Year: 2022

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer

Study further highlights potential of RaDaR to stratify patients and improve treatment outcomesFT. MYERS, FL / ACCESSWIRE / March 17,...

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

error: Content is protected !!